Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chemed Corp (NYSE:CHE)

190.74
Delayed Data
As of Sep 21
 +0.26 / +0.14%
Today’s Change
132.92
Today|||52-Week Range
216.01
+18.91%
Year-to-Date
Why Should Investors Add Amedisys (AMED) to Their Portfolio?
Sep 21 / Zacks.com - Paid Partner Content
CVS Health Gains on Pharmacy Services, Retail Remains a Drag
Sep 13 / Zacks.com - Paid Partner Content
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
Sep 21 / Zacks.com - Paid Partner Content
Medtronic (MDT) Begins Product Recall, Diabetes Group a Drag
Sep 12 / Zacks.com - Paid Partner Content
Why is Edwards Lifesciences (EW) a Strong Buy Stock Now?
Sep 21 / Zacks.com - Paid Partner Content
Zimmer Biomet (ZBH) Launches Persona Partial Knee System
Sep 12 / Zacks.com - Paid Partner Content
Here's Why You Should Add Chemed (CHE) to Your Portfolio
Sep 21 / Zacks.com - Paid Partner Content
Chemed Rides on VITAS Recovery, Robust Roto-Rooter Sales
Sep 08 / Zacks.com - Paid Partner Content
AmerisourceBergen's PharMEDium Slows Down, Competition Rife
Sep 13 / Zacks.com - Paid Partner Content
NuVasive Grows in Pediatric Deformity With New FDA Approval
Sep 08 / Zacks.com - Paid Partner Content